We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
BCAS1 / NABC1 antibody
Breast carcinoma-amplified sequence 1
Amplified and overexpressed in breast cancer
Novel amplified in breast cancer 1
Gene name: BCAS1, AIBC1, NABC1
Amplified and overexpressed in breast cancer
Novel amplified in breast cancer 1
Gene name: BCAS1, AIBC1, NABC1
As low as
$655.80
In stock
Ref
00097748
Breast Carcinoma Amplified Sequence 1 (BCAS1), also known as Novel Amplified in Breast Cancer 1 (NABC1) was isolated from a region at 20q13 and is amplified in several tumor types. It is associated with more aggressive tumor phenotypes. BCAS1/NABC1 is highly expressed in some, but not all, breast cancer cell lines and in some breast tumors at 20q13.2. The BCAS1/NABC1 gene is predicted to encode a protein of 584 amino acids with no significant homology to other proteins.
| ID Covalab | pab60042 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide corresponding to amino acids 532-550 of human BCAS1/NABC1. |
| Activity cross reaction | Reacts with human BCAS1. |
| Species | Hu |
| Labelling | None |
| Form | Purified |
| Preservative | None |
| Storage instructions | Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles. |
| Target | BCAS1 / NABC1 |
| Uniprot ID | O75363 |
| Gene ID | 8537 |
| Applications | IHC, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only: WB (1 - 5 µg/ml) |
Write Your Own Review